Overview

Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams

Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to compare the relative vasoconstrictive effects of test and reference Clobetasol Propionate 0.05% Topical Foam in healthy, female subjects.
Details
Lead Sponsor:
Padagis LLC
Perrigo Company
Treatments:
Clobetasol